What is Alymsys®?

Alymsys (bevacizumab-maly) is an anti-angiogenic therapy used to block the blood supply that feeds cancer tumors and prevents it from growing. This is different from chemotherapy, which attacks the cancer cells themselves. Alymsys is a biosimilar medication. To learn more about biosimilars click the button below.
Learn More


It’s easy to access the Amneal PATHways® Patient Support Program

PATHways provides you with a straight-forward range of resources and services designed to easily map your personal path toward more accessible medication. Learn what is available to you and how to keep things moving along your individual treatment path.

Amneal PATHways® Patient Support Program offers services such as:

  • Benefits investigation
  • Prior authorization support
  • Affordability options
  • Claims assistance